DNMT1 and ovarian carcinoma: However, the combination of the DNMT1 inhibitor, Azacytidine, with an irreversible inhibitor of polyamine biosynthesis, α-di-fluoromethylornithine, increased M1 macrophages in the TME of an ovarian cancer model (44).